Ongoing

The Memory Disorders Program is conducting the following ongoing clinical trials. These trials are underway and are no longer recruiting:

Status Title Trial Information Sponsor
Ongoing

Continued Safety Monitoring of Solanezumab in Alzheimer's Disease (EXPEDITION EXT)

Trial Eli Lilly & Co.
Ongoing

Alzheimer's Disease Neuroimaging Intiative 2

Trial

ADCS
Ongoing

A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects with Prodromal or Mild AD

Trial Biogen Idec
Ongoing

Effect of Passive Immunization on the Progression of Mild Alzheimer’s Disease: Solanezumab (LY2062430) versus Placebo (Expedition 3)

Trial Eli Lilly & Co.
Ongoing

An Efficacy and Safety Trial of MK-8931 in Mild to Moderate AD (EPOCH)

Trial Merck and Co.

A list of research studies that are Recruiting is also available.